|
|
|
|
| Cat. No. 443 008 |
50 µg purified recombinant IgG, lyophilized. Albumin and azide were added for stabilization. For reconstitution add 50 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use. Antibodies should be stored at +4°C when still lyophilized. Do not freeze! |
| Applications | |
| Clone | Rb174A6 |
| Subtype | IgG1 (κ light chain) |
| Immunogen | Synthetic peptide corresponding to the processed bioactive VIP neuropeptide cleaved from the mouse precursor (UniProt Id: P32648) |
| Reactivity |
Reacts with: mouse (P32648), rat (P01283), human (P01282). Other species not tested yet. |
| Remarks |
This antibody is a chimeric antibody based on a monoclonal rat antibody. The constant regions of the heavy and light chains have been replaced with rabbit specific sequences. Therefore, the antibody can be used with standard anti-rabbit secondary reagents. The antibody has been expressed in mammalian cells. |
| Data sheet | Data Sheet 443_008 |
|
|
VIP (Vasoactive intestinal peptide) is a 28 amino acid peptide hormone, a member of the secretin/glucagon superfamily, and evolutionarily well conserved. It is synthesized as part of a larger propeptide which is proteolytically processed to release bioactive VIP as well as two other neuropeptides.
VIP is expressed in gastrointestinal tissues and in the central and peripheral nervous system. It is released from neurons upon depolarization and is known to stimulate adenylyl cyclase.
In the brain, VIP acts as a neurotransmitter and is involved in rhythm generation in the suprachiasmatic nucleus, the regulation of neuroendocrine secretions in the hypothalamus and energy metabolism of glial cells.
Peripherally, VIP influences many functions including blood flow and cardiac output, smooth muscle activity, secretion in the digestive tract, gastric motility, bronchodilation and activity within the hypothalamic-pituitary-adrenal axis.
The Verner-Morrison or Watery Diarrhea Hypokalemia and Achlorhydria (WDHA) syndrome is a characteristic clinical syndrome associated with overproduction of VIP from endocrine tumors.
For more information on protein expression pattern, please refer to the overview image in our SYSY Antibodies ATLAS.